Frédéric Cantagrel

Title: Frédéric Cantagrel: Innovator in Anticancer Compounds

Introduction

Frédéric Cantagrel is a notable inventor based in Talence, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer properties. His work is characterized by a commitment to advancing medical science and improving treatment options for patients.

Latest Patents

Frédéric Cantagrel holds a patent for ngCycloartanone derivatives with anticancer activity. This invention relates to a compound of a specific formula, or to a pharmaceutically acceptable salt thereof. It also includes pharmaceutical compositions that utilize these compounds and their application as a drug, particularly for treating proliferative diseases such as cancer. He has 1 patent to his name.

Career Highlights

Throughout his career, Frédéric has worked with prominent organizations, including Pierre Fabre Medicament and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Frédéric has had the opportunity to work alongside talented individuals such as Christophe Long and Yves Guminski. These collaborations have enriched his research and fostered innovation in the development of new therapeutic compounds.

Conclusion

Frédéric Cantagrel's work in the field of anticancer compounds exemplifies the impact of innovative research on medical treatments. His contributions continue to inspire advancements in pharmaceutical science and offer hope for patients battling cancer.